Skip to main content

Current Status of New MAO-A/B Inhibitor Development

  • Chapter
Catecholamine Research

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 53))

  • 21 Accesses

Abstract

Although old MAO inhibitors, nonselective and irreversible MAO inhibitors, have antidepressive effects, they had serious side effects, such as hepatotoxicity caused by a hydrazine moiety, the cheese effect and orthostatic hypotension. Due to these adverse events, classical MAO inhibitors with a hydrazine moiety are no longer used clinically.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bonhomme, N. and Esposito, E., 1998, Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review. J. Clin. Psychopharmacol., 18, 447–54.

    Article  PubMed  CAS  Google Scholar 

  • Curet, O., Sontag, N., Aubin, N., Marc, C., Jegham, S., Puech, F., Burnier, P., George, P., Scatton, B., 2000, Biochemical profile of SL25.1131 a novel mixed and reversible MAO-A/B inhibitor. 30th Soc. Neurosci.Abs., 666.2, 2000 (New Orleans).

    Google Scholar 

  • Fahn, S. and Chouinard, S., 1998, Experience with tranylcypromine in early Parkinson’s disease, J Neural Transm [Suppl]. 52: 49–61.

    Article  CAS  Google Scholar 

  • Suzuki T, Akaike N, Ueno K, Tanaka Y, Himori, N., 1995, MAO inhibitors, clorgyline and lazabemide, prevent hydroxyl radical generation caused by brain ischemia/reperfusion in mice. Pharmacology, 50: 357–62.

    Article  PubMed  CAS  Google Scholar 

  • Speiser, Z., Mayk, A., Eliash, S., Cohen, S., 1999, Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat, J. Neural Transm., 106: 593–606.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Iwata, N. (2002). Current Status of New MAO-A/B Inhibitor Development. In: Nagatsu, T., Nabeshima, T., McCarty, R., Goldstein, D.S. (eds) Catecholamine Research. Advances in Behavioral Biology, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3538-3_33

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3538-3_33

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-3388-1

  • Online ISBN: 978-1-4757-3538-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics